New York Life Investment Management’s Enfusion, Inc. ENFN Stock Holding History

New York Life Investment Management’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-329,008	Closed	-$3.67M	–	845
2025 Q1	$3.67M	Buy	+329,008	New	+$3.64M	0.04%	390
2024 Q1	–	Sell	-33,144	Closed	-$321K	–	1554
2023 Q4	$321K	Sell	33,144 -765	-2%	-$7.15K	﹤0.01%	1174
2023 Q3	$304K	Sell	33,909 -5,342	-14%	-$50.7K	﹤0.01%	1141
2023 Q2	$440K	Sell	39,251 -6,838	-15%	-$60.6K	﹤0.01%	840
2023 Q1	$484K	Buy	+46,089	New	+$508K	0.01%	822

Other funds holding ENFN

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York Life Investment Management's ENFN Position: Q2 2025 in Review

New York Life Investment Management sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 329,008 shares — an estimated $3.67M sold.

New York Life Investment Management first reported a position in ENFN in Q1 2023 and held it in 5 quarters. The position peaked at $3.67M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

New York Life Investment Management reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
New York Life Investment Management sold 329,008 Enfusion, Inc. shares in Q2 2025, an estimated $3.67M.
New York Life Investment Management first reported a position in Enfusion, Inc. in Q1 2023 and held it in 5 quarters.
New York Life Investment Management's Enfusion, Inc. position peaked at $3.67M in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on New York Life Investment Management's 13F filing for Q2 2025, filed 1 Aug 2025.